'Lab-on-a-Chip' Technology Cuts Costs of Lab Tests
September 21, 2015 | RutgersEstimated reading time: 2 minutes
Rutgers engineers have developed a breakthrough device that can significantly reduce the cost of sophisticated lab tests for medical disorders and diseases, such as HIV, Lyme disease and syphilis.
The new device uses miniaturized channels and valves to replace “benchtop” assays – tests that require large samples of blood or other fluids and expensive chemicals that lab technicians manually mix in trays of tubes or plastic plates with cup-like depressions.
“The main advantage is cost – these assays are done in labs and clinics everywhere,” said Mehdi Ghodbane, who earned his doctorate in biomedical engineering at Rutgers and now works in biopharmaceutical research and development at GlaxoSmithKline.
Ghodbane and six Rutgers researchers recently published their results in the Royal Society of Chemistry’s journal, Lab on a Chip.
The lab-on-chip device, which employs microfluidics technology, along with making tests more affordable for patients and researchers, opens doors for new research because of its capability to perform complex analyses using 90 percent less sample fluid than needed in conventional tests.
“A great deal of research has been hindered because in many cases one is not able to extract enough fluid,” Ghodbane said.
The Rutgers breakthrough also requires one-tenth of the chemicals used in a conventional multiplex immunoassay, which can cost as much as $1500. Additionally, the device automates much of the skilled labor involved in performing tests.
“The results are as sensitive and accurate as the standard benchtop assay,’’ said Martin Yarmush, the Paul and Mary Monroe Chair and Distinguished Professor of biomedical engineering at Rutgers and Ghodbane’s adviser.
Until now, animal research on central nervous system disorders, such as spinal cord injury and Parkinson’s disease, has been limited because researchers could not extract sufficient cerebrospinal fluid to perform conventional assays.
“With our technology, researchers will be able to perform large-scale controlled studies with comparable accuracy to conventional assays,” Yarmush said.
The discovery could also lead to more comprehensive research on autoimmune joint diseases such as rheumatoid arthritis through animal studies. As with spinal fluid, the amount of joint fluid, or synovial fluid, researchers are able to collect from lab animals is minuscule.
The Rutgers team has combined several capabilities for the first time in the device they’ve dubbed “ELISA-on-a-chip” (for enzyme-linked immunosorbent assay). A single device analyzes 32 samples at once and can measure widely varying concentrations of as many as six proteins in a sample.
The researchers are exploring the commercial potential of their technology.
Other members of the research team are Elizabeth Stucky, a doctoral student in the Department of Chemical and Biochemical Engineering, and assistant research professor Tim Maguire, associate research professor Rene Schloss, professor David Shreiber and associate professor Jeffrey Zahn, all in the Department of Biomedical Engineering.
The National Institutes of Health, the National Science Foundation, the New Jersey Commission on Brain Injury Research and Corning, Inc. provided funding for the research.
About Rutgers School of Engineering
At Rutgers School of Engineering, students earn their Masters of Engineering in Biomedical Engineering, one of the fastest-growing fields in engineering today. The course is 100% online.
Suggested Items
Japanese Joint Research Group win Prime Minister’s Award with Ultra High-performance Computing Platform
03/25/2024 | FujitsuA Japanese consortium of research partners including RIKEN, the National Institute of Advanced Industrial Science and Technology (AIST), the National Institute of Information and Communications Technology (NICT), Osaka University, Fujitsu Limited, and Nippon Telegraph and Telephone Corporation (NTT) have been recognized with the prestigious Prime Minister’s Award.
Keysight Accelerates Its 6G Efforts with NVIDIA 6G Research Cloud Platform
03/22/2024 | Keysight Technologies, Inc.Keysight Technologies, Inc. is collaborating on the new NVIDIA 6G Research Cloud Platform, which includes the NVIDIA Aerial Omniverse Digital Twin, an open, flexible, and interconnected framework of network emulation resources offering researchers a comprehensive tool suite on which to develop new adaptations of artificial intelligence (AI) for radio access networks (RAN).
Foxconn Recognized as Top 100 Global Innovators 2024
03/07/2024 | FoxconnHon Hai Technology Group (Foxconn) announced it has been named a Top 100 Global Innovators™ 2024. The annual list from Clarivate™, a global leader in providing transformative intelligence, identifies organizations leading the world in technology research and innovation.
Siemens Joins Semiconductor Education Alliance to Address Skills and Talent Shortage in Global Semiconductor Industry
03/04/2024 | SiemensSiemens Digital Industries Software announced it has joined the Semiconductor Education Alliance to help build and nurture thriving communities of practice across the integrated circuit (IC) design and Electronic Design Automation (EDA) industries, from teachers and schools to universities, publishers, educational technology companies and research organizations.
Siemens Joins Semiconductor Education Alliance to Address Skills and Talent Shortage in Global Semiconductor Industry
02/29/2024 | Siemens Digital IndustriesSiemens Digital Industries Software announced today it has joined the Semiconductor Education Alliance to help build and nurture thriving communities of practice across the integrated circuit (IC) design and Electronic Design Automation (EDA) industries, from teachers and schools to universities, publishers, educational technology companies and research organizations.